NIBBIO, Gabriele
 Distribuzione geografica
Continente #
NA - Nord America 2.139
AS - Asia 1.977
EU - Europa 1.349
SA - Sud America 490
AF - Africa 53
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.009
Nazione #
US - Stati Uniti d'America 2.029
SG - Singapore 797
IT - Italia 544
CN - Cina 475
BR - Brasile 415
HK - Hong Kong 214
DE - Germania 194
VN - Vietnam 153
BD - Bangladesh 111
FR - Francia 96
FI - Finlandia 94
GB - Regno Unito 88
RU - Federazione Russa 71
TR - Turchia 63
CA - Canada 58
UA - Ucraina 46
IN - India 38
MX - Messico 34
CZ - Repubblica Ceca 33
PL - Polonia 30
NL - Olanda 27
AR - Argentina 23
AT - Austria 23
IE - Irlanda 21
SE - Svezia 21
ZA - Sudafrica 21
ID - Indonesia 18
IQ - Iraq 18
JP - Giappone 18
EC - Ecuador 14
PY - Paraguay 13
ES - Italia 11
PK - Pakistan 10
SA - Arabia Saudita 9
AL - Albania 8
UZ - Uzbekistan 8
CO - Colombia 7
LT - Lituania 7
MA - Marocco 7
PT - Portogallo 7
NP - Nepal 6
EG - Egitto 5
PE - Perù 5
AE - Emirati Arabi Uniti 4
BE - Belgio 4
BG - Bulgaria 4
CR - Costa Rica 4
ET - Etiopia 4
IL - Israele 4
PA - Panama 4
PH - Filippine 4
TT - Trinidad e Tobago 4
VE - Venezuela 4
AO - Angola 3
CL - Cile 3
DZ - Algeria 3
KE - Kenya 3
KG - Kirghizistan 3
KZ - Kazakistan 3
PS - Palestinian Territory 3
RO - Romania 3
TN - Tunisia 3
UY - Uruguay 3
AZ - Azerbaigian 2
BO - Bolivia 2
CH - Svizzera 2
CY - Cipro 2
DK - Danimarca 2
HU - Ungheria 2
IR - Iran 2
JO - Giordania 2
NO - Norvegia 2
OM - Oman 2
RS - Serbia 2
SN - Senegal 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
DM - Dominica 1
EU - Europa 1
FK - Isole Falkland (Malvinas) 1
GR - Grecia 1
IM - Isola di Man 1
JM - Giamaica 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
ML - Mali 1
NI - Nicaragua 1
TH - Thailandia 1
TJ - Tagikistan 1
Totale 6.009
Città #
Singapore 406
Ashburn 277
Hong Kong 214
San Jose 199
New York 131
Beijing 110
Milan 103
The Dalles 103
Los Angeles 98
Munich 96
Brescia 70
Helsinki 70
Lauterbourg 60
Fairfield 57
Chandler 55
Boardman 52
Ho Chi Minh City 49
Istanbul 49
São Paulo 40
Chicago 38
Dallas 34
Princeton 34
Council Bluffs 31
Hanoi 30
Moscow 30
Seattle 30
Redondo Beach 29
Warsaw 27
Woodbridge 27
Buffalo 26
Cambridge 26
Shanghai 26
Jacksonville 25
Orem 25
Santa Clara 25
San Francisco 24
Wilmington 24
Brno 23
Frankfurt am Main 23
Houston 23
Dublin 21
London 21
Romola 19
Rome 18
Turku 18
Toronto 16
Des Moines 15
Düsseldorf 15
Ann Arbor 14
Brooklyn 14
Montreal 14
Nuremberg 14
Palazzolo sull'Oglio 14
Stockholm 14
Tokyo 14
Turin 14
Amsterdam 13
Mexico City 13
Atlanta 11
Denver 11
Haiphong 11
Manchester 11
Belo Horizonte 10
Johannesburg 10
Porto Alegre 10
Ankara 9
Charlotte 9
Guangzhou 9
Naples 9
Olomouc 9
Changsha 8
Dearborn 8
Nanjing 8
New Delhi 8
Padua 8
Paris 8
Phoenix 8
Tashkent 8
Campinas 7
Jakarta 7
Poplar 7
Rio de Janeiro 7
San Diego 7
Venice 7
Asunción 6
Bergamo 6
Curitiba 6
Guayaquil 6
Hangzhou 6
Jinan 6
Lappeenranta 6
Querétaro 6
Verona 6
Vienna 6
Brasília 5
Chennai 5
Clifton 5
Da Nang 5
Elk Grove Village 5
Lisbon 5
Totale 3.415
Nome #
Adult ADHD: Prevalence and Clinical Correlates in a Sample of Italian Psychiatric Outpatients 198
Autistic symptoms predict social cognitive performance in patients with schizophrenia 170
Autistic Symptoms in Schizophrenia: Impact on Internalized Stigma, Well-Being, Clinical and Functional Characteristics 159
Effectiveness, Core Elements, and Moderators of Response of Cognitive Remediation for Schizophrenia: A Systematic Review and Meta-analysis of Randomized Clinical Trials 143
Adult ADHD and sleep disorders: Prevalence, severity and predictors of sleep disorders in a sample of Italian psychiatric outpatients 142
Impact of Physical Exercise Alone or in Combination with Cognitive Remediation on Cognitive Functions in People with Schizophrenia: A Qualitative Critical Review 134
Cognitive impairment after recovery from COVID-19: Frequency, profile, and relationships with clinical and laboratory indices 133
Evidence-Based Integrated Intervention in Patients with Schizophrenia: A Pilot Study of Feasibility and Effectiveness in a Real-World Rehabilitation Setting 128
Acceptability of cognitive remediation for schizophrenia: A systematic review and meta-analysis of randomized controlled trials 125
The Elephant in the Room: A Cross-Sectional Study on the Stressful Psychological Effects of the COVID-19 Pandemic in Mental Healthcare Workers 125
Efficacy and tolerability of Brain Stimulation interventions in Borderline Personality Disorder: state of the art and future perspectives – A systematic review 119
Current Evidence and Theories in Understanding the Relationship between Cognition and Depression in Childhood and Adolescence: A Narrative Review 118
Cognitive and clinical characteristics of offenders and non-offenders diagnosed with schizophrenia spectrum disorders: results of the Recoviwel observational study 117
Social Cognition in a Research Domain Criteria Perspective: A Bridge Between Schizophrenia and Autism Spectra Disorders 116
Autistic Symptoms and Social Cognition Predict Real-World Outcomes in Patients With Schizophrenia 115
Improving depressive symptoms in patients with schizophrenia using bilateral bipolar-nonbalanced prefrontal tDCS: Results from a double-blind sham-controlled trial 114
Durability of Effects of Cognitive Remediation on Cognition and Psychosocial Functioning in Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Clinical Trials 113
Application of cognitive remediation in the world: new experiences from two schizophrenia rehabilitation centers in Togo and Benin 110
Psychological impact of Covid-19 pandemic in mental healthcare workers: a cross-sectional study in an Italian Department of Mental Health 110
Paliperidone extended-release in the short- and long-term treatment of schizophrenia 106
Effects of bilateral, bipolar-nonbalanced, frontal transcranial Direct Current Stimulation (tDCS) on negative symptoms and neurocognition in a sample of patients living with schizophrenia: Results of a randomized double-blind sham-controlled trial 103
Life engagement in people living with schizophrenia: predictors and correlates of patient life engagement in a large sample of people living in the community 99
The economic burden of schizophrenia spectrum disorders: clinical and functional correlates and predictors of direct costs. A retrospective longitudinal study 96
Autistic symptoms in unaffected first-degree relatives of people with schizophrenia: results from the Italian Network for Research on Psychoses multicenter study 95
Implementation of cognitive rehabilitation interventions for schizophrenia in low-income countries: An experience from Togo and Benin 94
Primary and secondary negative symptoms severity and the use of psychiatric care resources in schizophrenia spectrum disorders: A 3-year follow-up longitudinal retrospective study 93
Autistic symptoms in people with schizophrenia: Neurocognitive, socio-cognitive, clinical and real-world functional characteristics of individuals without autistic features 93
The role of pharmacogenetics in the treatment of major depressive disorder: a critical review 91
Assessment and correlates of autistic symptoms in Schizophrenia Spectrum Disorders measured with the PANSS Autism Severity Score: A systematic review 91
Internalized stigma among people with schizophrenia: Relationship with socio-demographic, clinical and medication-related features 90
Schizophrenia during the COVID-19 pandemic 89
Personality traits and disorders among adult ADHD Patients: Is borderline personality disorder as common as we expect? 86
The Relationship between Cognitive Impairment and Violent Behavior in People Living with Schizophrenia Spectrum Disorders: A Critical Review and Treatment Considerations 86
Long-acting Injectable Antipsychotics during the COVID-19 pandemic in schizophrenia: An observational study in a real-world clinical setting 85
Blood homocysteine concentration and mood disorders with mixed features among patients with alcohol use disorder 84
Shared and distinct abnormalities in sleep-wake patterns and their relationship with the negative symptoms of Schizophrenia Spectrum Disorder patients 83
European Psychiatric Association guidance on treatment of cognitive impairment in schizophrenia 82
Treatment of Cognitive Impairment Associated with Schizophrenia Spectrum Disorders: New Evidence, Challenges, and Future Perspectives 81
Verso la medicina di precisione in psichiatria: validazione clinica di un approccio farmacogenomico combinato nel trattamento del Disturbo Depressivo Maggiore 79
Conceptualization and characterization of "primary" and "secondary" cognitive impairment in schizophrenia 79
The influence of autistic symptoms on social and non-social cognition and on real-life functioning in people with schizophrenia: Evidence from the Italian Network for Research on Psychoses multicenter study 78
Is It Possible to Combine Non-Invasive Brain Stimulation and Evidence-Based Psychosocial Interventions in Schizophrenia? A Critical Review 77
What impact can brain stimulation interventions have on borderline personality disorder? 77
Paliperidone palmitate in short- and long-term treatment of schizophrenia 76
Well-Being and Mental Health: Where Do We Stand After COVID-19 Pandemic? 73
The interplay between childhood trauma, hopelessness, depressive symptoms, and mental pain in a large sample of patients with severe mental disorders: A network analysis 72
Efficacy of Functional Remediation on Cognitive and Psychosocial Functioning in Patients with Bipolar Disorder: Study Protocol for a Randomized Controlled Study 70
Patient-reported outcomes in the clinical management of depression: current status and future directions 70
Does social cognition change? Evidence after 4 years from the Italian Network for Research on Psychoses 69
Socio-demographic and clinical characteristics of SARS-CoV-2-positive psychiatric in-patients: A case-control study in the psychiatric wards of a Great Metropolitan Hospital in Milan 68
Predictors of psychosocial functioning in people diagnosed with schizophrenia spectrum disorders that committed violent offences and in those that did not: Results of the Recoviwel study 67
Evidence-based psychosocial interventions in schizophrenia: A critical review 65
Non-pharmacological interventions to improve cognitive impairment and psychosocial functioning in schizophrenia: a critical review 64
Does pharmacogenetic testing optimise antidepressant effectiveness in major depressive disorder? Data from a double blind randomized controlled trial in a real-world setting 63
Editorial: Case reports in schizophrenia and psychotic disorders 58
The role of pharmacogenetics in the treatment of major depressive disorder: a critical review 58
Effectiveness and Safety of Bright Light Therapy in Oncological Patients: A Systematic Review 56
Prevalence of cocaine use and cocaine use disorder among adult patients with attention-deficit/hyperactivity disorder: A systematic review and meta-analysis 54
Gender Differences in Anxiety and Depression before and after Alcohol Detoxification: Anxiety and Depression as Gender-Related Predictors of Relapse 54
Editorial: Methods and applications in psychopathology: new methods and trends for the understanding of neuropsychiatric disorders 53
Insulin-resistance as a modifiable pathway to cognitive dysfunction in schizophrenia: A systematic review 52
Editorial: Case reports in Schizophrenia and psychotic disorders: 2023 50
Pharmacological Treatment of Cognitive Impairment Associated With Schizophrenia: State of the Art and Future Perspectives 49
MCMI-III Personality Disorders, Traits, and Profiles in Adult ADHD Outpatients 45
Treatment of Comorbid Adult Attention-deficit/Hyperactivity Disorder and Generalized Anxiety Disorder: 2 Case Reports 43
Editorial: Cognitive and mental health improvement under- and post-COVID-19, volume III 42
Reply to: “Letter to the Editor: Cocaine use and cocaine use disorder - Revisiting epidemiology and clinical impact” 40
Editorial: Cognitive and mental health improvement under- and post-COVID-19 38
Longitudinal impact of CYP2D6 and CYP2C19 metabolizer status on antidepressant response: The role of Pharmacogenetic mismatch 22
Mild motor signs in major depressive disorder: prevalence and clinical profile 12
Totale 6.089
Categoria #
all - tutte 31.341
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.341


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202123 0 0 0 0 0 0 0 0 0 0 0 23
2021/2022131 7 19 8 7 5 6 4 10 7 15 6 37
2022/2023236 21 2 0 13 14 46 20 35 42 7 21 15
2023/2024559 21 15 50 41 32 87 25 12 71 28 4 173
2024/20251.424 26 29 39 165 147 110 129 70 193 134 216 166
2025/20263.444 338 396 252 528 343 229 410 163 203 273 212 97
Totale 6.089